Jeffrey S. Parkin

Array ( [id] => 3948099 [patent_doc_number] => 05955342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region' [patent_app_type] => 1 [patent_app_number] => 8/290105 [patent_app_country] => US [patent_app_date] => 1994-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10184 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955342.pdf [firstpage_image] =>[orig_patent_app_number] => 290105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656623 [patent_doc_number] => 05627025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Method for the identification of compounds capable of abrogating human immunodeficiency virus (HIV) infection of dendritic cells and T-lymphocytes' [patent_app_type] => 1 [patent_app_number] => 8/290432 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 46 [patent_no_of_words] => 20400 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627025.pdf [firstpage_image] =>[orig_patent_app_number] => 290432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 477387 [patent_doc_number] => 07223410 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-29 [patent_title] => 'Inactivated respiratory syncytial viral vaccines' [patent_app_type] => utility [patent_app_number] => 08/286189 [patent_app_country] => US [patent_app_date] => 1994-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7570 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223410.pdf [firstpage_image] =>[orig_patent_app_number] => 08286189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679167 [patent_doc_number] => 07083795 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-01 [patent_title] => 'Inactivated respiratory syncytial viral vaccines' [patent_app_type] => utility [patent_app_number] => 08/583124 [patent_app_country] => US [patent_app_date] => 1994-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7583 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083795.pdf [firstpage_image] =>[orig_patent_app_number] => 08583124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3644896 [patent_doc_number] => 05637453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Whole blood method and kit for the detection of antibodies against human immunodeficiency virus (HIV) in HIV-seronegative individuals' [patent_app_type] => 1 [patent_app_number] => 8/275933 [patent_app_country] => US [patent_app_date] => 1994-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4382 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637453.pdf [firstpage_image] =>[orig_patent_app_number] => 275933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269107 [patent_doc_number] => 06322964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/268388 [patent_app_country] => US [patent_app_date] => 1994-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8567 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322964.pdf [firstpage_image] =>[orig_patent_app_number] => 268388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182496 [patent_doc_number] => 06093405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines' [patent_app_type] => 1 [patent_app_number] => 8/167867 [patent_app_country] => US [patent_app_date] => 1994-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11511 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093405.pdf [firstpage_image] =>[orig_patent_app_number] => 167867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3543350 [patent_doc_number] => 05554524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'More complex type retroviruses having mixed type LTR, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/264115 [patent_app_country] => US [patent_app_date] => 1994-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 4404 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554524.pdf [firstpage_image] =>[orig_patent_app_number] => 264115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592753 [patent_doc_number] => 20020042045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL\nHTLV-II nra ENVELOPE PEPTIDES' [patent_app_type] => new [patent_app_number] => 08/259451 [patent_app_country] => US [patent_app_date] => 1994-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10687 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042045.pdf [firstpage_image] =>[orig_patent_app_number] => 08259451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506823 [patent_doc_number] => 06440656 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Methods for the inhibition of respiratory syncytial virus transmission' [patent_app_type] => B1 [patent_app_number] => 08/255208 [patent_app_country] => US [patent_app_date] => 1994-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 45694 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440656.pdf [firstpage_image] =>[orig_patent_app_number] => 08255208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4251494 [patent_doc_number] => 06222024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Nucleic acids encoding a human immunodeficiency virus type 1 (HIV-1) integrase interactor protein (INI-1)' [patent_app_type] => 1 [patent_app_number] => 8/248355 [patent_app_country] => US [patent_app_date] => 1994-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 10629 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/222/06222024.pdf [firstpage_image] =>[orig_patent_app_number] => 248355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766498 [patent_doc_number] => 05773225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Screening method for the identification of compounds capable of abrogation HIV-1 gag-cyclophilin complex formation' [patent_app_type] => 1 [patent_app_number] => 8/248357 [patent_app_country] => US [patent_app_date] => 1994-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 11907 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773225.pdf [firstpage_image] =>[orig_patent_app_number] => 248357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588208 [patent_doc_number] => 05585263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Purified retroviral constitutive transport enhancer and its use to facilitate mRNA transport, and to produce recombinant, attenuated HIV' [patent_app_type] => 1 [patent_app_number] => 8/246987 [patent_app_country] => US [patent_app_date] => 1994-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 12709 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585263.pdf [firstpage_image] =>[orig_patent_app_number] => 246987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646473 [patent_doc_number] => 05639598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions' [patent_app_type] => 1 [patent_app_number] => 8/246177 [patent_app_country] => US [patent_app_date] => 1994-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14520 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639598.pdf [firstpage_image] =>[orig_patent_app_number] => 246177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549131 [patent_doc_number] => 05571712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats' [patent_app_type] => 1 [patent_app_number] => 8/239427 [patent_app_country] => US [patent_app_date] => 1994-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9333 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571712.pdf [firstpage_image] =>[orig_patent_app_number] => 239427 [rel_patent_id] =>[rel_patent_doc_number] =>)